IMP3 and osteosarcoma: Both gain and loss of function of Imp3 in osteosarcoma cells revealed that Imp3 confers the ability to undergo anchorage-independent growth, loss of contact inhibition, and resistance to anoikis in vitro, all of which contribute to the development of tumorgenic potential.